Best Inc Reduces IPO Deal Size, Cuts Pricing, Then Settles for Just US$10 Per ADS
After reducing the size of its offering and slashing the price range for its ADSs on Tuesday morning, Best Inc reportedly priced its shares at just...
236 Views
Zai Lab IPO: Thoughts on Valuation, Risks and Upsides (Part 2)
In our first insight, we covered the company's background, particularly its management team and its product pipeline.In this insight, we will...
2k Views
Zai Lab IPO: Experienced Team, Promising In-Licensing Drug Pipeline (Part 1)
Zai Lab is looking to raise US$100m in the US listing. The company has a short history of three years and does not have a commercial product at the...
1.5k Views